A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC) ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other pharma stocks.

Though they are both multiple myeloma drugs with the same mechanism of action, Sanofi’s Sarclisa has had difficulty competing ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) ...

Walgreens to pay $300 million to resolve allegations it unlawfully dispensed and billed for millions of opioid and controlled substance prescriptions, with an additional $50 million penalty if ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The chief executive of Johnson & Johnson has warned that potential US tariffs on the pharmaceutical ...